Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s Lotemax. Lupin is the exclusive first-to-file for this product and may be eligible to ...

The Bible's lex talionis—"Eye for eye, tooth for tooth, hand for hand, foot for foot" (Exodus 21:24–27)—has captured the human imagination for millennia. This idea of fairness has been a ...

Introduction: The purpose of this study is to determine baseline demographics and utilization trend of an on-demand, synchronous tele-ophthalmology triage program in evaluating acute ophthalmic ...

Loteprednol Etabonate Ophthalmic Gel, 0.38% is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery Lupin is the exclusive first-to-file for ...

Loteprednol Etabonate Ophthalmic Gel, 0.38% is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery. Budget 2025 Expectations: Pharma ...

Global pharma major Lupin Limited (Lupin) announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for ...